| 27.06 0.19 (0.71%) | 09-18 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 32.13 |
1-year : | 37.52 |
| Resists | First : | 27.51 |
Second : | 32.13 |
| Pivot price | 26.14 |
|||
| Supports | First : | 25.79 |
Second : | 24.73 |
| MAs | MA(5) : | 26.89 |
MA(20) : | 25.96 |
| MA(100) : | 23.99 |
MA(250) : | 23.06 |
|
| MACD | MACD : | 0.6 |
Signal : | 0.5 |
| %K %D | K(14,3) : | 86.3  |
D(3) : | 87.7 |
| RSI | RSI(14): 63.3 |
|||
| 52-week | High : | 28 | Low : | 16.62 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ AVTR ] has closed below upper band by 17.4%. Bollinger Bands are 4.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 27.53 - 27.66 | 27.66 - 27.78 |
| Low: | 26.29 - 26.44 | 26.44 - 26.58 |
| Close: | 26.82 - 27.05 | 27.05 - 27.27 |
Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.
Wed, 18 Sep 2024
CCLA Investment Management Acquires 408,360 Shares of Avantor, Inc. (NYSE:AVTR) - MarketBeat
Tue, 17 Sep 2024
Sofinnova Investments Inc. Has $2.99 Million Holdings in Avantor, Inc. (NYSE:AVTR) - MarketBeat
Tue, 17 Sep 2024
Analysts Set Avantor, Inc. (NYSE:AVTR) Price Target at $27.40 - MarketBeat
Tue, 17 Sep 2024
Avantor (AVTR) Rallied 26% in July - Insider Monkey
Tue, 17 Sep 2024
Avantor (AVTR) Rallied 26% in July - Yahoo Finance UK
Thu, 12 Sep 2024
Avantor® Achieves Bronze Medal from EcoVadis for Sustainability Performance - StockTitan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Basic Materials
|
|
|
Industry:
Chemicals - Specialty
|
|
| Shares Out | 680 (M) |
| Shares Float | 677 (M) |
| Held by Insiders | 1.2 (%) |
| Held by Institutions | 98.3 (%) |
| Shares Short | 36,690 (K) |
| Shares Short P.Month | 33,330 (K) |
| EPS | 0.51 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 8 |
| Profit Margin | 5.2 % |
| Operating Margin | 10.3 % |
| Return on Assets (ttm) | 3.6 % |
| Return on Equity (ttm) | 6.9 % |
| Qtrly Rev. Growth | -2.5 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 10.04 |
| EBITDA (p.s.) | 1.7 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 905 (M) |
| Levered Free Cash Flow | 709 (M) |
| PE Ratio | 52.03 |
| PEG Ratio | 3.8 |
| Price to Book value | 3.38 |
| Price to Sales | 2.69 |
| Price to Cash Flow | 20.32 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|